# Manzo Pharmaceuticals, Inc: Form D filing

Manzo Pharmaceuticals, Inc, a pharmaceuticals company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2015. The latest, on December 10, 2015, reports an offering of no set size with nothing sold yet.

Find out what Manzo Pharmaceuticals, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Manzo%20Pharmaceuticals%2C%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Manzo%20Pharmaceuticals%2C%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fmanzo-pharmaceuticals-inc-1637132)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Manzo%20Pharmaceuticals%2C%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Manzo%20Pharmaceuticals%2C%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fmanzo-pharmaceuticals-inc-1637132)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 222-415 Oakdale Road, Toronto, Ontario, Canada, M3N 1
- Phone: (647) 393-8417
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Nevada
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1637132

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 10, 2015 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1637132/000163713215000003/0001637132-15-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Arthur Douglas Smitherman | Director |  |

[Every Form D from the week of Dec 7, 2015](https://specstream.ai/data/form-d/week/2015-12-07) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Manzo Pharmaceuticals, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).